VITAMIN D3 DEFICIENCY
Abstract
Vitamin D deficiency is common and may contribute to osteopenia, osteoporosis and falls risk in the elderly. Screening for vitamin D deficiency is important in high-risk patients, especially for patients who suffered minimal trauma fractures. Vitamin D deficiency should be treated according to the severity of the deficiency. In high-risk adults, follow-up serum 25-hydroxyvitamin D concentration should be measured 3–4 months after initiating maintenance therapy to confirm that the target level has been achieved. All patients should maintain a calcium intake of at least 1,000 mg for women aged ≤ 50 years and men ≤ 70 years, and 1,300 mg for women > 50 years and men > 70 years.
References
1. Adams JS, Lee G. Gains in bone mineral density with resolution of Vitamin D intoxication. Ann Intern Med 1997; 127:203–6.
2. Anık A, Çatlı G, Abacı A, Dizdaric, Böber E. Acute Vitamin D intoxication possibly due to faulty production of a multivita- min preparation. J Clin Res Pediatr Endocrinol 2013; 5:136–9. 26. 27. Maji D. Vitamin D toxicity. Indian J Endocrinol Metab 2012; 16:295–6. [CrossRef ].
3. Araki T, Holick MF, Alfonso BD, Charlap E, Romero CM, Rizk D, et al. Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supple- ments made in the United States. J Clin Endocrinol Metab 2011;96:3603–8. [CrossRef ].
4. Armas, L.A.G.; Hollis, B.W.; Heaney, R.P. Vitamin D2 is much less effective than vitamin D3 in humans. J. Clin. Endocrinol. Metab. 2004, 89, 5387–5391.
5. Biancuzzo, R.M.; Young, A.; Bibuld, D.; Cai, M.H.; Winter, M.R.; Klein, E.K.; Ameri, A.; Reitz, R.;Salameh, W.; Chen, T.C.; et al. Fortification of orange juice with vitamin D2 or vitamin D3 is as effective as an oral supplement in maintaining vitamin D status in adults. Am. J. Clin. Nutr. 2010, 91, 1621–1626.
6. Binkley, N.; Gemar, D.; Engelke, J.; Gangnon, R.; Ramamurthy, R.; Krueger, D.; Drezner, M.K. Evaluation of ergocalciferol or cholecalciferol dosing, 1600 IU daily or 50,000 IU monthly in older adults. J. Clin. Endocrinol. Metab. 2011, 96, 981–988.
7. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339:b3692.
8. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized control.
9. Bouillon R. Vitamin D: From photosynthesis, metabolism, and action to clinical application. In: Endocrinology. 6th ed. 2010.p1089–110.
10. Bouillon R. Vitamin D: from photo- synthesis, metabolism, and action to clini- cal applications. In: DeGroot LJ, Jameson JL, eds. Endocrinology. Philadelphia: W.B. Saunders, 2001:1009-28.
11. Deluca HF, Prahl JM, Plum LA 1,25-dihydroxy Vitamin D is not responsible for toxicity caused by Vitamin D or 25-hydroxy Vitamin D. Arch Biochem Biophys 2011;505:226–30. [CrossRef ]
12. DeLuca HF. Overview of general phys- iologic features and functions of vitamin D. Am J Clin Nutr 2004;80:Suppl:1689S- 1696S.
13. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005;289:F8-F28.
14. Glendenning, P.; Chew, G.T.; Seymour, H.M.; Gillett, M.J.; Goldswain, P.R.; Inderjeeth, C.A.; Vashikaran, S.D.; Taranto, M.; Musk, A.A.; Fraser, W.D. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone 2009, 45, 870–875.
15. Gordon, C.M.; Williams, A.L.; Feldman, H.A.; May, J.; Sinclair, L.; Vasquez, A.; Cox, J.E. Treatment of hypovitaminosis D in infants and toddlers. J. Clin. Endocrinol. Metab. 2008, 93, 2716–2721.
16. Heaney, R.P.; Recker, R.R.; Grote, J.; Horst, R.L.; Armas, L.A. Vitamin D3 is more potent than vitamin D2 in humans. J. Clin. Endocrinol. Metab. 2010, 96, E447–E452.
17. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment,and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96:1911-30.
18. Holick MF, Garabedian M. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. In: Fa- vus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metab-olism. 6th ed. Washington, DC: American Society for Bone and Mineral Research, 2006:129-37.
19. Holick, M.F.; Biancuzzo, R.M.; Chen, T.C.; Klein, E.K.; Young, A.; Bibuld, D.; Reitz, R.; Salameh, W.; Ameri, A.; Tannenbaum, A.D. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J. Clin. Endocrinol. Metab. 2008, 93, 677–681.
20. Holick MF, Siris ES, Binkley N, et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90:3215-24.
21. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81.
22. Hruska KA. Hyperphosphatemia and hypophosphatemia. In: Favus, MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 6thed. Washington, DC: American Society for Bone and Mineral Research, 2006:233-42.
23. Leventis, P.; Kiely, P.D. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scandal. J. Rheumatol. 2009, 38, 149–153.
24. Maji D. Vitamin D toxicity. Indian J Endocrinol Metab 2012;16:295–6. [CrossRef ].
25. Misra M, Pacaud D, Petryk A et al. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122(2):398–417. [PubMed] [Google Scholar].
26. Nimesh M, Singh P, Jhamb U, Dubey A P. An unsuspected pharmacological Vitamin D toxicity in a child and its brief re- view of literature. Toxicol İnt 2015;22:167. [CrossRef ].
27. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, non specific musculoskeletal pain. Mayo Clin Proc 2003; 78:1463-70.
28. Reis JP, von Muhlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007;30:1549-55.
29. Romagnoli, E.; Mascia, M.L.; Cipriani, C.; Fassino, V.; Mazzei, F.; D’Erasmo, E.; Carnevale, V.; Scillitani, A.; Minisola, S. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J. Clin. Endocrinol. Metab. 2008, 93, 3015–3020.
30. Sezer RG, Guran T, Paketçi C, Seren LP, Bozaykut A, Bereket A, et al. Comparison of oral alendronate versus prednisolone in treatment of infants with Vitamin D intoxication. Acta Paediatr 2012;101:e122–5. [CrossRef ].
31. THolick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116:2062-72.
32. Wagner CL, Greer FR, American Academy of Pediatrics Section on Breastfeeding, American Academy of Pediatrics Committee on Nutrition. Prevention of rickets and Vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;122:1142–52.
33. Whayne TF Jr. Vitamin D: Popular cardiovascular supplement but bene t must be evaluated. Int J Angiol 2011;20:63–72.
34. Zhou C, Assem M, Tay JC et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest. 2006;116(6):1703–1712. [PMC free article] [PubMed] [Google Scholar].
